Raineri, Davide http://orcid.org/0000-0003-3327-6305
Dianzani, Chiara http://orcid.org/0000-0002-2246-3183
Cappellano, Giuseppe
Maione, Federica http://orcid.org/0000-0003-2789-799X
Baldanzi, Gianluca http://orcid.org/0000-0002-1370-9903
Iacobucci, Ilaria http://orcid.org/0000-0001-6210-5607
Clemente, Nausicaa http://orcid.org/0000-0002-9860-0148
Baldone, Giulia
Boggio, Elena http://orcid.org/0000-0003-2700-3597
Gigliotti, Casimiro L. http://orcid.org/0000-0002-3127-5686
Boldorini, Renzo
Rojo, Josè M. http://orcid.org/0000-0001-9032-0072
Monti, Maria http://orcid.org/0000-0002-7775-7154
Birolo, Leila
Dianzani, Umberto http://orcid.org/0000-0001-6723-3931
Chiocchetti, Annalisa
Article History
Received: 9 January 2020
Accepted: 30 September 2020
First Online: 26 October 2020
Competing interests
: A.C., U.D., C.D., E.B., and C.L.G. are listed as inventors on the patent PCT/IB2019/050154 “Novel anti-tumor therapeutic agents”. E.B., U.D., and C.L.G. are founders of an UPO Spinoff (NOVAICOS). All other authors declare no competing interests.